Endometrial cancer · Women treated with ovary‐stimulating drugs for subfertility
It is very uncertain whether exposure to gonadotropins for subfertility changes endometrial cancer compared with untreated subfertile women and endometrial cancer risk (very low certainty).
1 finding from 1 review
Endometrial cancer · Women treated with ovary‐stimulating drugs for subfertility
It is very uncertain whether exposure to gonadotropins for subfertility changes endometrial cancer compared with general population and endometrial cancer risk (very low certainty).
1 finding from 1 review
Endometrial cancer · Women treated with ovary‐stimulating drugs for subfertility
It is very uncertain whether exposure to GnRH analogues for subfertility changes endometrial cancer compared with untreated subfertile women and endometrial cancer risk (very low certainty).
1 finding from 1 review
Endometrial cancer · Women treated with ovary‐stimulating drugs for subfertility
It is very uncertain whether exposure to clomiphene citrate for subfertility changes endometrial cancer compared with untreated subfertile women and endometrial cancer risk (very low certainty).
1 finding from 1 review
Endometrial cancer · Women treated with ovary‐stimulating drugs for subfertility
It is very uncertain whether exposure to clomiphene citrate for subfertility changes endometrial cancer compared with general population and endometrial cancer risk (very low certainty).
1 finding from 1 review
Endometrial cancer · Women treated with ovary‐stimulating drugs for subfertility
It is very uncertain whether exposure to any ovary‐stimulating drugs for subfertility changes endometrial cancer compared with untreated subfertile women and endometrial cancer risk (very low certainty).
1 finding from 1 review
Endometrial cancer · Women treated with ovary‐stimulating drugs for subfertility
It is very uncertain whether exposure to any ovary‐stimulating drugs for subfertility changes endometrial cancer compared with general population and endometrial cancer risk (very low certainty).
1 finding from 1 review
Endometrial cancer · Women treated with ovary‐stimulating drugs for subfertility
It is very uncertain whether exposure to clomiphene citrate and gonadotropins for subfertility changes endometrial cancer compared with untreated subfertile women and endometrial cancer risk (very low certainty).
1 finding from 1 review
Endometrial cancer · Women treated with ovary‐stimulating drugs for subfertility
It is very uncertain whether exposure to clomiphene citrate and gonadotropins for subfertility changes endometrial cancer compared with general population and endometrial cancer risk (very low certainty).
1 finding from 1 review
Stomach cancer risk (18 studies) · adults (aged at least 18 years)
It is very uncertain whether highest changes stomach cancer risk (18 studies) compared with lowest green tea exposure (very low certainty).
1 finding from 1 review
RR 0.86 [0.74, 1.01]
438595 participants
Very low
Liver cancer risk (6 studies) · adults (aged at least 18 years)
Highest showed no clear difference in liver cancer risk (6 studies) compared with lowest green tea exposure (low certainty).
1 finding from 1 review
RR 0.88 [0.68, 1.14]
198885 participants
Low
Pancreatic cancer risk (9 studies) · adults (aged at least 18 years)
Highest showed no clear difference in pancreatic cancer risk (9 studies) compared with lowest green tea exposure (low certainty).
1 finding from 1 review
RR 0.88 [0.7, 1.1]
326564 participants
Low
Colorectal cancer risk (16 studies) · adults (aged at least 18 years)
Highest may leads to lower colorectal cancer risk (16 studies) compared with lowest green tea exposure (low certainty).
1 finding from 1 review
RR 0.84 [0.74, 0.96]
610295 participants
Low
Colon cancer risk (10 studies) · adults (aged at least 18 years)
Highest may leads to lower colon cancer risk (10 studies) compared with lowest green tea exposure (low certainty).
1 finding from 1 review
RR 0.89 [0.8, 0.98]
389974 participants
Low
Rectal cancer risk (9 studies) · adults (aged at least 18 years)
Highest showed no clear difference in rectal cancer risk (9 studies) compared with lowest green tea exposure (low certainty).
1 finding from 1 review
RR 0.89 [0.75, 1.05]
356851 participants
Low
Lung cancer risk (17 studies) · adults (aged at least 18 years)
It is very uncertain whether highest changes lung cancer risk (17 studies) compared with lowest green tea exposure (very low certainty).
1 finding from 1 review
RR 0.88 [0.76, 1.02]
269565 participants
Very low
Breast cancer risk (14 studies) · adults (aged at least 18 years)
It is very uncertain whether highest changes breast cancer risk (14 studies) compared with lowest green tea exposure (very low certainty).
1 finding from 1 review
RR 0.88 [0.75, 1.02]
250822 participants
Very low
Gynaecological cancer risk (10 studies) · adults (aged at least 18 years)
Highest may leads to lower gynaecological cancer risk (10 studies) compared with lowest green tea exposure (low certainty).
1 finding from 1 review
RR 0.69 [0.57, 0.83]
66738 participants
Low
Endometrial cancer risk (5 studies) · adults (aged at least 18 years)
Highest may leads to lower endometrial cancer risk (5 studies) compared with lowest green tea exposure (low certainty).
1 finding from 1 review
RR 0.77 [0.65, 0.91]
60416 participants
Low
Ovarian cancer risk (5 studies) · adults (aged at least 18 years)
Highest may leads to lower ovarian cancer risk (5 studies) compared with lowest green tea exposure (low certainty).
1 finding from 1 review
RR 0.64 [0.45, 0.9]
6322 participants
Low